Search

everythinglearnresearchcommunity

for

Search:↓

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Most studies on perioral dermatitis treatment are of low quality, with some agreement on oral tetracycline effectiveness and stopping steroids and cosmetics.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Scalp hair follicle culture has limits for testing minoxidil's hair growth effects.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Researchers suggest using a standard question and 5-point scale to measure patient satisfaction with acne scar treatments.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Microneedling is a safe and effective treatment for various skin conditions, often preferred for its fewer side effects and shorter recovery time.

Minoxidil effectively treats female pattern hair loss.

There is a significant need for better-validated quality of life tools in dermatology.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

People with depression often have higher hair cortisol levels, while those with PTSD tend to have lower levels, but more research is needed to understand this fully.

No treatment is completely effective for alopecia totalis and alopecia universalis.

PRP shows promise for hair loss treatment, but needs standardized preparation and composition.

Vacuum massage may improve skin elasticity and induce changes in skin cells, but evidence for treating burn scars is insufficient and more research is needed.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Fractional laser therapy is a promising, effective, and minimally invasive treatment for hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Acidic sandy clay damages archaeological hair the most, while dry conditions preserve but make it brittle; silicone oil can help keep the hair flexible.